These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38062845)
1. Differential Expression Patterns of Toll-like Receptors in COVID-19 Patients. Lee N; Ko R; Lee SY Front Biosci (Landmark Ed); 2023 Nov; 28(11):307. PubMed ID: 38062845 [TBL] [Abstract][Full Text] [Related]
2. Role of Toll-like receptors in the pathogenesis of COVID-19. Khanmohammadi S; Rezaei N J Med Virol; 2021 May; 93(5):2735-2739. PubMed ID: 33506952 [TBL] [Abstract][Full Text] [Related]
4. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Root-Bernstein R Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738 [TBL] [Abstract][Full Text] [Related]
5. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans. Choudhury A; Das NC; Patra R; Mukherjee S J Med Virol; 2021 Apr; 93(4):2476-2486. PubMed ID: 33404091 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments. Liu ZM; Yang MH; Yu K; Lian ZX; Deng SL Front Pharmacol; 2022; 13():989664. PubMed ID: 36188605 [TBL] [Abstract][Full Text] [Related]
7. Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3 Abdolmohammadi-Vahid S; Baradaran B; Sadeghi A; Bezemer GFG; Kiaee F; Adcock IM; Folkerts G; Garssen J; Mortaz E Exp Mol Pathol; 2024 Jun; 137():104897. PubMed ID: 38691979 [TBL] [Abstract][Full Text] [Related]
8. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection. Jung HE; Lee HK Viruses; 2021 Oct; 13(11):. PubMed ID: 34834939 [TBL] [Abstract][Full Text] [Related]
9. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection. Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500 [TBL] [Abstract][Full Text] [Related]
10. Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease. Vakil MK; Mansoori Y; Al-Awsi GRL; Hosseinipour A; Ahsant S; Ahmadi S; Ekrahi M; Montaseri Z; Pezeshki B; Mohaghegh P; Sohrabpour M; Bahmanyar M; Daraei A; Dadkhah Jouybari T; Tavassoli A; Ghasemian A J Med Virol; 2022 Sep; 94(9):4088-4096. PubMed ID: 35538614 [TBL] [Abstract][Full Text] [Related]
11. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. Choudhury A; Mukherjee S J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269 [TBL] [Abstract][Full Text] [Related]
12. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants. Kayesh MEH; Kohara M; Tsukiyama-Kohara K Viruses; 2021 Nov; 13(11):. PubMed ID: 34835108 [TBL] [Abstract][Full Text] [Related]
13. Expression analysis of nine Toll-like receptors in yellow catfish (Pelteobagrus fulvidraco) responding to Aeromonas hydrophila challenge. Zhang XT; Zhang GR; Shi ZC; Yuan YJ; Zheng H; Lin L; Wei KJ; Ji W Fish Shellfish Immunol; 2017 Apr; 63():384-393. PubMed ID: 28223111 [TBL] [Abstract][Full Text] [Related]
14. TLRs1-10 Protein Expression in Circulating Human White Blood Cells during Bacterial and COVID-19 Infections. Chomel L; Vogt M; Demiselle J; Le Borgne P; Tschirhart M; Morandeau V; Merdji H; Miguet L; Helms J; Meziani F; Mauvieux L J Innate Immun; 2024; 16(1):216-225. PubMed ID: 38461810 [TBL] [Abstract][Full Text] [Related]
15. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus. Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336 [TBL] [Abstract][Full Text] [Related]
16. mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients. Bagheri-Hosseinabadi Z; Rezazadeh Zarandi E; Mirabzadeh M; Amiri A; Abbasifard M BMC Infect Dis; 2022 May; 22(1):448. PubMed ID: 35538443 [TBL] [Abstract][Full Text] [Related]
17. Pattern-recognition receptors (PRRs) in SARS-CoV-2. Isazadeh A; Heris JA; Shahabi P; Mohammadinasab R; Shomali N; Nasiri H; Valedkarimi Z; Khosroshahi AJ; Hajazimian S; Akbari M; Sadeghvand S Life Sci; 2023 Sep; 329():121940. PubMed ID: 37451397 [TBL] [Abstract][Full Text] [Related]
18. From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children. Root-Bernstein R Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769320 [TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract. Xu M; Li N; Fan X; Zhou Y; Bi S; Shen A; Wang B Microbiol Spectr; 2022 Feb; 10(1):e0114421. PubMed ID: 35196817 [TBL] [Abstract][Full Text] [Related]
20. Role of toll-like receptors in the pathogenesis of COVID-19: Current and future perspectives. Yang MY; Zheng MH; Meng XT; Ma LW; Liang HY; Fan HY Scand J Immunol; 2023 Aug; 98(2):e13275. PubMed ID: 38441378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]